These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15304353)

  • 1. Phosphorylated alpha-synuclein in normal mouse brain.
    Hirai Y; Fujita SC; Iwatsubo T; Hasegawa M
    FEBS Lett; 2004 Aug; 572(1-3):227-32. PubMed ID: 15304353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of alpha-synuclein in different brain parts of adult and aged rats.
    Adamczyk A; Solecka J; Strosznajder JB
    J Physiol Pharmacol; 2005 Mar; 56(1):29-37. PubMed ID: 15795473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear and neuritic distribution of serine-129 phosphorylated alpha-synuclein in transgenic mice.
    Schell H; Hasegawa T; Neumann M; Kahle PJ
    Neuroscience; 2009 Jun; 160(4):796-804. PubMed ID: 19272424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ultrastructural distribution of alpha-synuclein-like protein in normal mouse brain.
    Totterdell S; Hanger D; Meredith GE
    Brain Res; 2004 Apr; 1004(1-2):61-72. PubMed ID: 15033420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination of alpha-synuclein.
    Nonaka T; Iwatsubo T; Hasegawa M
    Biochemistry; 2005 Jan; 44(1):361-8. PubMed ID: 15628878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental models of Parkinson's disease.
    Beal MF
    Nat Rev Neurosci; 2001 May; 2(5):325-34. PubMed ID: 11331916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
    Muntané G; Ferrer I; Martinez-Vicente M
    Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson's disease.
    Poon HF; Frasier M; Shreve N; Calabrese V; Wolozin B; Butterfield DA
    Neurobiol Dis; 2005 Apr; 18(3):492-8. PubMed ID: 15755676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein.
    Wakamatsu M; Ishii A; Ukai Y; Sakagami J; Iwata S; Ono M; Matsumoto K; Nakamura A; Tada N; Kobayashi K; Iwatsubo T; Yoshimoto M
    J Neurosci Res; 2007 Jun; 85(8):1819-25. PubMed ID: 17465029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analysis of alpha-synuclein and its significance].
    Nonaka T; Iwatsubo T; Hasegawa M
    Nihon Rinsho; 2004 Sep; 62(9):1623-8. PubMed ID: 15462375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo modulation of polo-like kinases supports a key role for PLK2 in Ser129 α-synuclein phosphorylation in mouse brain.
    Bergeron M; Motter R; Tanaka P; Fauss D; Babcock M; Chiou SS; Nelson S; San Pablo F; Anderson JP
    Neuroscience; 2014 Jan; 256():72-82. PubMed ID: 24128992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies.
    Iwata A; Maruyama M; Akagi T; Hashikawa T; Kanazawa I; Tsuji S; Nukina N
    Hum Mol Genet; 2003 Oct; 12(20):2625-35. PubMed ID: 12928483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein.
    Yavich L; Oksman M; Tanila H; Kerokoski P; Hiltunen M; van Groen T; Puoliväli J; Männistö PT; García-Horsman A; MacDonald E; Beyreuther K; Hartmann T; Jäkälä P
    Neurobiol Dis; 2005 Nov; 20(2):303-13. PubMed ID: 16242637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and glial accumulation of alpha- and beta-synucleins in human lipidoses.
    Suzuki K; Iseki E; Togo T; Yamaguchi A; Katsuse O; Katsuyama K; Kanzaki S; Shiozaki K; Kawanishi C; Yamashita S; Tanaka Y; Yamanaka S; Hirayasu Y
    Acta Neuropathol; 2007 Nov; 114(5):481-9. PubMed ID: 17653558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective alterations of gene expression in mice induced by MPTP.
    Xu Z; Cawthon D; McCastlain KA; Slikker W; Ali SF
    Synapse; 2005 Jan; 55(1):45-51. PubMed ID: 15499605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of mRNA coding for alpha-, beta-, and gamma-synuclein in the brains of newborn, juvenile, and adult rats.
    Malatynska E; Pinhasov A; Crooke J; Horowitz D; Brenneman DE; Ilyin SE
    J Mol Neurosci; 2006; 29(3):269-77. PubMed ID: 17085784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.
    Shirakashi Y; Kawamoto Y; Tomimoto H; Takahashi R; Ihara M
    Acta Neuropathol; 2006 Dec; 112(6):681-9. PubMed ID: 16957925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of an alpha-synuclein peptide fragment enhances metal binding.
    Liu LL; Franz KJ
    J Am Chem Soc; 2005 Jul; 127(27):9662-3. PubMed ID: 15998051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
    Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
    Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.